DANA-FARBER CANCER INSTITUTE
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1947-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.dana-farber.org/
Sleep Treatment Education Program-1 (STEP-1)
Not Applicable
Completed
- Conditions
- InsomniaCancer Survivors
- Interventions
- Behavioral: Sleep Treatment Education Program (STEP-1)Behavioral: Enhanced Usual Care
- First Posted Date
- 2022-08-29
- Last Posted Date
- 2024-10-23
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 70
- Registration Number
- NCT05519982
- Locations
- 🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States
Home Transfusion for HEME
Not Applicable
Recruiting
- Conditions
- Hematologic Malignancy
- Interventions
- Other: Home Transfusion Program Components
- First Posted Date
- 2022-08-22
- Last Posted Date
- 2024-12-03
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 20
- Registration Number
- NCT05509439
- Locations
- 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Olaparib in Unresectable/Metastatic Melanoma With BRCA1/2
Phase 2
Withdrawn
- Conditions
- Recurrent Metastatic MelanomaCutaneous MelanomaMucosal MelanomaUveal Melanoma
- Interventions
- First Posted Date
- 2022-08-01
- Last Posted Date
- 2024-01-19
- Lead Sponsor
- Dana-Farber Cancer Institute
- Registration Number
- NCT05482074
InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
Recruiting
- Conditions
- Childhood Cancer SurvivorsAdenomatous HyperplasiaHigh-risk Oral Precancerous DiseasesHereditary Cancer PredictionIARC CarcinogensNon-Alcoholic Fatty Liver DiseaseHigh Grade Prostatic Epithelial NeoplasiaSerous Tubal Intraepithelial CarcinomaCervical and Endocervical Carcinoma in SituNephrogenic Rests
- Interventions
- Other: Samples
- First Posted Date
- 2022-07-19
- Last Posted Date
- 2024-07-31
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 5000
- Registration Number
- NCT05463796
- Locations
- 🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States
STAMP+CBT mHealth for Cancer Pain
Not Applicable
Completed
- Conditions
- Active CancerActive Cancer TreatmentChronic Pain Due to CancerAdvanced CancerPalliative Care
- Interventions
- Behavioral: STAMP+CBT application
- First Posted Date
- 2022-06-03
- Last Posted Date
- 2025-01-01
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 10
- Registration Number
- NCT05403801
- Locations
- 🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸Dana-Farber at Merrimack Valley, Methuen, Massachusetts, United States
🇺🇸Dana-Farber at Londonderry, Londonderry, New Hampshire, United States
Early Interventional Treatment for Cancer Pain
Not Applicable
Active, not recruiting
- Conditions
- Cancer Pain
- Interventions
- Other: Early ReferralOther: Pain Management Strategies
- First Posted Date
- 2022-05-09
- Last Posted Date
- 2024-10-01
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 30
- Registration Number
- NCT05366413
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸Dana Farber Cancer Institute, Boston, Massachusetts, United States
Sleep Treatment Education Program for Young Adult Cancer Survivors (STEP-YA)
Not Applicable
Recruiting
- Conditions
- CancerInsomnia Due to Medical ConditionInsomnia
- Interventions
- Behavioral: STEP-YA with CoachingBehavioral: STEP-YA without Coaching
- First Posted Date
- 2022-05-03
- Last Posted Date
- 2024-03-21
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 74
- Registration Number
- NCT05358951
- Locations
- 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Resistance Exercise Combined With Protein Supplementation in People With Pancreatic Cancer: The RE-BUILD Trial
Not Applicable
Recruiting
- Conditions
- Pancreatic Cancer
- Interventions
- Behavioral: Resistance Training (RT) and Protein Supplementation (PS)Behavioral: Resistance Training (RT)Behavioral: Attention Control (AC
- First Posted Date
- 2022-05-02
- Last Posted Date
- 2024-02-21
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 45
- Registration Number
- NCT05356117
- Locations
- 🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States
Intraoral Photobiomodulation Therapy to Prevent Oral Mucositis in Patients Undergoing Hematopoietic Cell Transplantation
Not Applicable
Recruiting
- Conditions
- Mucosal UlcerMyeloablative Allogeneic Hematopoietic Cell TransplantationIntraoral Photobiomodulation TherapyOral Mucositis
- Interventions
- Device: THOR LX2.3 with LED Lollipop
- First Posted Date
- 2022-04-19
- Last Posted Date
- 2024-11-05
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 20
- Registration Number
- NCT05335434
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
Exercise to Enhance Cardiovascular Health Among Black Prostate Cancer Patients With Androgen Deprivation Therapy
Not Applicable
Recruiting
- Conditions
- Androgen Deprivation TherapyProstate CancerProstate Cancer Metastatic
- Interventions
- Other: Aerobic and resistance exerciseOther: Usual Care
- First Posted Date
- 2022-04-14
- Last Posted Date
- 2024-01-23
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 62
- Registration Number
- NCT05327465
- Locations
- 🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States
© Copyright 2025. All Rights Reserved by MedPath